| 1. | blackopsstreet | |
| 2. | BUYtheWeak | |
| 3. | sueellen | |
| 4. | charmor126 | |
| 5. | clarkfan |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | sueellen 10/02/2017 Ignyta Announces New Data Highlighting Immuno-Oncological Efficacy of RXDX-106 at 2017 AACR Tumor Immunology and Immunotherapy Meeting |
| 2. | blackopsstreet 10/18/2017 They need to raise money for manufacturing in anticipation of approval 2018 |
| 3. | BUYtheWeak 10/03/2017 I predict a partnership agreement very soon. |
| 4. | charmor126 10/18/2017 Trump killed biotech today |
| 5. | clarkfan 10/18/2017 Upped price target from 15 to 23 |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Ignyta, Inc.
- RXDX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.